NCT00445341
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,249 public trials
217 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT02219737
- Conditions
- CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
NCT00281814
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients
NCT01472887
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Investigational Site Number 840001 Denver, Colorado, United States
- Investigational Site Number 840003 Augusta, Georgia, United States
- Investigational Site Number 840005 Boise, Idaho, United States
- Investigational Site Number 056002 Ghent, Belgium
NCT02142530
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +27 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Conditions
- Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Buenos Aires, Argentina
- Corrientes, Argentina
- Santa Fe, Argentina
- Canberra, Australian Capital Territory, Australia
NCT00073957
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Fletcher Allen Health Care - Medical Center Campus Burlington, Vermont, United States
NCT00619645
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +49 more
- Locations
-
- University of California Davis Cancer Center Sacramento, California, United States
NCT00867529
- Conditions
- B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +83 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation
NCT02252146
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- Emory University Atlanta, Georgia, United States
- Cancer Care Specialists of Illinois Decatur, Illinois, United States
- Horizon Bio Advance Lafayette, Indiana, United States